Table 2 Clinical characteristics of patients whose serum was tested for PCSK9 levels. The patients with HCC had significantly higher PCSK9 than healthy controls, as well as those with cirrhosis and chronic hepatitis
From: Decreased PCSK9 expression in human hepatocellular carcinoma
Clinical characteristics | HCC (N = 40) | Cirrhosis (N = 13) | Chronic Hepatitis (N = 38) | Healthy controls (N = 6) |
|---|---|---|---|---|
Average PCSK9 (ng/mL) | 91.6 | 78.3 | 69.2 | 92.1 |
Alphafetoprotein levels | 30.1 | N.A. | N.A. | N.A. |
Average tumor diameter (SD) | 5.64 (3.88) | N.A. | N.A. | N.A. |